Its location on the surface of myelin led to initial speculation of its immunogenicity in multiple sclerosis (MS) but results were inconsistent, reflecting detection of non-conformational MOG epitopes and older generation assay techniques (enzyme-linked-immunosorbent-assay [ELISA]) [3]. This evidence concerns the gene MOG and myeloid sarcoma.